Effectiveness of the XBB.1.5 COVID-19 Vaccines Against SARS-CoV-2 Hospitalisation Among Adults Aged ≥ 65 Years During the BA.2.86/JN.1 Predominant Period, VEBIS Hospital Study, Europe, November 2023 to May 2024. - Antunes L; Rojas-Castro M; Lozano M; Martínez-Baz I; Leroux-Roels I; Borg ML; Oroszi B; Fitzgerald M; Dürrwald R; Jancoriene L; Machado A; Petrović G; et al. (Influenza and other respiratory viruses, 2025)